These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26199396)

  • 21. Spondyloarthritis: Low-dose CT for spondyloarthritis - a brilliant new chapter?
    Maksymowych WP; Lambert RG
    Nat Rev Rheumatol; 2018 Mar; 14(3):130-131. PubMed ID: 29367690
    [No Abstract]   [Full Text] [Related]  

  • 22. [Spondylo-arthritis in Togolese patients].
    Mijiyawa M; Grunitzky K; Agbanouvi EA; Agbetra A
    Ann Med Interne (Paris); 1991; 142(8):582-6. PubMed ID: 1807178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model.
    Van Praet L; Van den Bosch FE; Jacques P; Carron P; Jans L; Colman R; Glorieus E; Peeters H; Mielants H; De Vos M; Cuvelier C; Elewaut D
    Ann Rheum Dis; 2013 Mar; 72(3):414-7. PubMed ID: 23139267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPARTAN annual meeting, New York City 2014.
    Espinoza LR
    Clin Rheumatol; 2015 Jun; 34(6):985-6. PubMed ID: 25939521
    [No Abstract]   [Full Text] [Related]  

  • 25. Association study of LMP gene polymorphisms in Mexican patients with spondyloarthritis.
    Vargas-Alarcón G; Gamboa R; Zuñiga J; Fragoso JM; Hernández-Pacheco G; Londoño J; Pacheco-Tena C; Cardiel MH; Granados J; Burgos-Vargas R
    Hum Immunol; 2004 Dec; 65(12):1437-42. PubMed ID: 15603870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis.
    Kenna TJ; Davidson SI; Duan R; Bradbury LA; McFarlane J; Smith M; Weedon H; Street S; Thomas R; Thomas GP; Brown MA
    Arthritis Rheum; 2012 May; 64(5):1420-9. PubMed ID: 22144400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are there new emerging drugs for ankylosing spondylitis or spondyloarthritis?
    Wendling D
    Expert Opin Emerg Drugs; 2013 Mar; 18(1):5-7. PubMed ID: 23216081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Th17 and interleukin 23 in the pathogenesis of psoriatic arthritis and spondyloarthritis.
    Cauli A; Mathieu A
    J Rheumatol Suppl; 2012 Jul; 89():15-8. PubMed ID: 22751583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Klebsiella related antigens in ankylosing spondylitis.
    Beaulieu AD; Rousseau F; Israël-Assayag E; Roy R
    J Rheumatol; 1983 Feb; 10(1):102-5. PubMed ID: 6341581
    [No Abstract]   [Full Text] [Related]  

  • 30. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis.
    Ciccia F; Accardo-Palumbo A; Alessandro R; Rizzo A; Principe S; Peralta S; Raiata F; Giardina A; De Leo G; Triolo G
    Arthritis Rheum; 2012 Jun; 64(6):1869-78. PubMed ID: 22213179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of the immunological indices in the early diagnosis of ankylosing spondyloarthritis].
    Starostina NM; Shirinskiĭ VS; Lozovoĭ VP
    Revmatologiia (Mosk); 1985; (1):22-4. PubMed ID: 3890077
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of spondyloarthropathy: the potential for agents other than TNF inhibitors.
    Her M; Kavanaugh A
    Curr Opin Rheumatol; 2013 Jul; 25(4):455-9. PubMed ID: 23680779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis.
    Ciccia F; Alessandro R; Rizzo A; Accardo-Palumbo A; Raimondo S; Raiata F; Guggino G; Giardina A; De Leo G; Sireci G; Triolo G
    Rheumatology (Oxford); 2014 Jan; 53(1):104-13. PubMed ID: 24080254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Spondyloarthritis - the novel concept. An introduction to the diagnosis and treatment of axial spondyloarthritis].
    Kiltz U; Baraliakos X; Braun J
    Dtsch Med Wochenschr; 2012 Sep; 137(36):1745-7. PubMed ID: 22933197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In situ analysis of interleukin-23- and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis.
    Appel H; Maier R; Bleil J; Hempfing A; Loddenkemper C; Schlichting U; Syrbe U; Sieper J
    Arthritis Rheum; 2013 Jun; 65(6):1522-9. PubMed ID: 23508523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunologic disorders in ankylosing spondylitis].
    Sadovska-Vroblevska M
    Ter Arkh; 1981; 53(7):22-5. PubMed ID: 6794171
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study of the phenomenon of discordance of HLA-B27 during the course of ankylosing spondylitis].
    Huaux JP; De Bruyere M; Nagant de Deuxchaisnes C
    Acta Rhumatol; 1979; 3(2):128-42; discussion 142-3. PubMed ID: 11496651
    [No Abstract]   [Full Text] [Related]  

  • 38. Ankylosing spondylitis with selective IgA deficiency and a circulating anticoagulant.
    Good AE; Cassidy JT; Mutchnick MG; Reed RE; Lederman HM
    J Rheumatol; 1977; 4(3):297-302. PubMed ID: 926106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ankylosing spondylitis and related spondyloarthropathies: the dramatic advances in the past decade.
    Khan MA
    Rheumatology (Oxford); 2011 Apr; 50(4):637-9. PubMed ID: 21421688
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis.
    Geczy AF; Seager K; Bashir HV; de Vere-Tyndall A; Edmonds J
    J Clin Lab Immunol; 1980 Jan; 3(1):23-8. PubMed ID: 7381924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.